Generated August 21, 2026 at 8:33 PM ET
· Covers August 21 trading day
· 7 of 165 ready 8-Ks selected
· AI-assisted overview
The day's filings were dominated by regulatory and financial distress events, with three companies—Silexion Therapeutics (SLXN), urban-gro (UGRO), and Adial Pharmaceuticals (ADIL)—receiving Nasdaq delisting notices for equity shortfalls or listing compliance issues, each planning appeals or compliance plans. M&A activity was also prominent: Elutia (ELUT) completed the sale of its Women's Health assets for $11M, Werewolf Therapeutics (HOWL) announced a reverse merger with Ambros valued at $500M alongside a $150M PIPE, and Evolution Petroleum (EPM) closed a $16M Midland Basin acquisition. Direct Digital Holdings (DRCT) secured loan default waivers and a Nasdaq extension to September 15. Overall, the filings reflect a mix of listing challenges and strategic corporate actions.
SLXN
Silexion Therapeutics Corp
regulatory
negative
materiality 0.90
August 21, 2026, 4:21 PM ET
Silexion receives Nasdaq delisting notice for equity shortfall; plans appeal
- Nasdaq delisting notice received Aug 18, 2026 for failure to meet $2.5M shareholders' equity requirement (Rule 5550(b)(1)).
- Shareholders' equity as of June 30, 2026 was only $44,000, far below required minimum.
- Company intends to appeal by Aug 25, 2026; under Mandatory Hearings Panel Monitor limiting compliance extensions.
regulatory
negative
materiality 0.85
August 21, 2026, 5:28 PM ET
Flash Sports & Media faces Nasdaq suspension Aug 26; company seeks hearing
- Nasdaq Staff Determination on Aug 19, 2026: reverse merger (Feb 17, 2025) was a Change of Control; initial listing application not completed before conversion.
- Stockholders removed 19.9% cap on June 12, 2026; Series B converted to 53,539,119 common shares on June 23, 2026.
- Nasdaq will suspend trading at open on Aug 26, 2026; company will request hearing by 4:00 p.m. ET that day.
ADIL
ADIAL PHARMACEUTICALS, INC.
regulatory
negative
materiality 0.85
August 21, 2026, 5:17 PM ET
Adial receives Nasdaq delisting notice for equity shortfall
- On Aug 18, 2026, Nasdaq said stockholders' equity fell below $2.5M minimum for continued listing.
- Company also fails alternative $35M market value or $500K net income standards.
- Must submit compliance plan by Oct 2, 2026; intends to convert Series A preferred stock at 2026 annual meeting.
M&A
positive
materiality 0.80
August 21, 2026, 5:00 PM ET
Elutia completes SimpliDerm sale to Cellution for $11M; adds $7.7M net cash
- Closed Aug 17, 2026 sale of Women's Health hADM assets to Cellution Biologics.
- Received $7.7M net cash ($8M at close less inventory adjustments); up to $3M contingent milestones over 18 months.
- Transaction treated as discontinued operations; estimated pre-tax gain of $4.9M.
HOWL
Werewolf Therapeutics, Inc.
M&A
positive
materiality 1.00
August 21, 2026, 9:10 AM ET
Werewolf to merge with Ambros in reverse merger; Ambros valued at $500M, PIPE of $150M
- Merger Sub to merge into Ambros; Ambros stockholders to own ~71.7% of combined company; Werewolf pre-merger holders ~6.8%.
- Concurrent PIPE financing of $150M from qualified investors; proceeds condition to close; implies Werewolf valuation $47.5M.
- Werewolf stockholders get CVRs for legacy WTX-124 and WTX-330 assets; no assurance of payments.
EPM
EVOLUTION PETROLEUM CORP
M&A
positive
materiality 0.75
August 21, 2026, 4:17 PM ET
Evolution Petroleum closes $16M Midland Basin mineral & royalty acquisition
- Closed purchase of ~3,420 net royalty acres across Reagan, Upton, Glasscock, Midland, Martin counties, Texas.
- Total price $16M, effective Aug 1, 2026; funded with stock offering proceeds, cash, credit facility.
- Acquired interests expected ~$3.9M NTM asset cash flow, ~4.1x multiple; production ~210 BOE/d (65% liquids).
DRCT
Direct Digital Holdings, Inc.
debt
negative
materiality 0.80
August 21, 2026, 9:02 AM ET
Direct Digital Holdings gets loan default waivers, Nasdaq extension to Sept 15
- Lender waives Q2 2026 covenant breaches: min cash $450k, leverage ≤3.50x, fixed charge ≥1.25x, EBITDA ≥$200k.
- Missed interest for May-July 2026 and Twelfth Amendment fees deferred to Sept 30, 2026; August interest also due then.
- Waivers for cash covenant and refinancing/preferred transaction defaults expire Aug 31, 2026; compliance required Sept 1.